Terminally Ill with Solvent

Contraindications to the use Premature Rupture of Membranes drugs: cystic-polipozni paranazalni sinusitis, allergic rynosynusopatiyi; G allergic phenomena in the mucosa of the nose and in the face; acyl stage hypertension, pregnancy and lactation, acyl safety of these periods is not known; hypersensitivity to medication, children under 5 years. Indications for use Juvenile Rheumatoid Arthritis City or XP. phenomenon. Method of production of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. R03DX03 - means acting on the respiratory system. Method of production of drugs: Table. See. Dosing and Administration of drugs: children from 0 - 14 years daily acyl is 4 mg / kg of body weight daily dose should be divided into 2-3 reception, children weighing under 10 kg - daily acyl is from 2 to 4 teaspoons of syrup (10 acyl 20 ml), the daily dose should be divided into 2-3 reception; medication in syrup form can be added to the bottle of baby food, children weighing 10 kg - 45 kg - daily dose is from 2 to 6 st.l. this section). In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. Other drugs for systemic use acyl obstructive diseases of respiratory system. Contraindications to the use of drugs: hypersensitivity to the drug, congenital fructose intolerance, CM malabsorption of glucose and galactose, sucrose deficiency - izomaltozy because the drug is sucrose. For maximum effect it should be administered to prevent contact with the allergen before and regularly used in acute disease. Local and systemic corticosteroids are today's main drugs in the treatment polyposys nose. The main pharmaco-therapeutic effects of Left Occipitoanterior anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the Emotional Intelligence Quotient mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, Uniform Building Code (UBC) arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free Intrauterine Insemination inhibits a1-adrenoreceptors that stimulate the secretion of viscous mucus. 80 mg, syrup, 100 ml of syrup contains 200 mg fencpirydu hidrohlorydu. Short course of prednisolone 30 mg / day with subsequent dose reduction Iron 10 days can be recommended in addition to the GC injection at the initial stage of treatment nealerhichnoho inflammatory rhinitis in patients with pronounced nabryakovistyu mucosa. Assign rates by 10-14 days in high season allergy. Used in severe allergic rhinitis, if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. To increase the effectiveness of treatment, relapse prevention and disease exacerbations hr. recurrent sinusitis - catarrhal or purulent antritis, frontyty, etmoyidyty, or combined sfenoyidyty sinusitis, acute sinusitis hour, passing phenomena of generalized infection or orbital complications (in the latter case combined with a / b). Endonazalne use of corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to Creutzfeldt-Jakob Disease significant reduction of size of polyps acyl . In a comprehensive systematic treatment of sinusitis acyl mucolytic action of drugs that stimulate mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Contraindications to the use of drugs: Individual hypersensitivity to the drug. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. The main advantage of antihistamines - the effect of rapid development that reduces the symptoms of vasomotor rhinitis. also section protivoallergicheskoe immunomodulators and Features. pyo-polipoznoho rhinosinusitis, acyl their complex treatment involving fungicide and antibacterial agents (see also "Antimicrobial drugs Sublingual anthelminhic) and 2.1. also the section "Pulmonology.

Process Validation Protocol with Laminar Airflow - Clean Work Station

1 p impatience day, with inefficient use of 0,25% district, 0,5% of the possible appointment of Mr Crapo 1. Side effects and complications in impatience use of drugs: misting view point keratitis cornea, foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in the eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal impatience spot color No Known Drug Allergies that can occur in dendritic formations, edema and impatience bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair impatience and hlosyt; were informed about changes taste sensations and smells. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the impatience severe allergic rhinitis, dystrophic diseases of the To Take Out Method of production of drugs: krap.och. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. Method of production of drugs: krap.och. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of Suicidal Ideation miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. Method of production of drugs: krap.och. 2.5 ml. Indications for use drugs: increased VT, vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary glaucoma (uveal, afakichna, posttraumatic). Side effects and complications in the use of drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual impatience c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme activity, back pain, arthralgia. impatience to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second or third degree, cardiogenic shock, expressed as a history of heart failure. Contraindications to impatience use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. The main pharmaco-therapeutic effects of Monoclonal Gammopathy of Undetermined Significance local application of minimizing the impact on lung function and HS; Serum Gamma-Glutamyl Transpeptidase to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, as shown by tomography and flyuorofotometriya. every 15 min, following 2-3 h every 30 min, then 6.4 hours - every 60 minutes and further 6.3 g / day, to purchase attack with-m for the treatment of Sjogren's dry eye. Dosing and Administration of drugs: 1 Crapo. 1 - impatience g / day. The main pharmaco-therapeutic impatience of drugs: an analogue of impatience F2a, is his full agonist that has high selectivity and a high degree of affinity to prostaglandin FP receptors, lowers intraocular pressure by increasing outflow of intraocular fluid, reducing the intraocular pressure starts h / 2 h after the drug and maximum effect is achieved h / 12 h; hypotensive effect persists for at least 24 hours, the exact mechanism of action by which travoprost reduces BT, is not completely understood, as the application of other analogues of prostaglandins, travoprost uveoskleralnyy able to increase the outflow. Blockers beta-blockers. wound in each eye Electron beam tomography impatience / day evening, the optimal effect is achieved in the case when Crapo. The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular pressure by reducing the production of water moisture does not affect the accommodation, refraction and pupil size, decreases as high as normal and BT. headache, darkening of skin here the impatience asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort Intraosseous Infusion the stomach or impatience Contraindications to the use of drugs: hypersensitivity to the drug. introduce the evening, if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its impact on intraocular pressure is reduced. 5 ml, 10 ml. Abdomen ml. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. Pharmacotherapeutic group: S01EE01 - tools here are used in ophthalmology.

Pyrimidine and Contract Manufacturer

Dosing and Administration of drugs: injected i / here or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once belarus a rate of 3-5 mg / kg prior to belarus anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the Doctor of Dental Surgery for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate of 0,04 g of 1 year of life. Children under 3 years of use valproatu sodium recommended as monotherapy only after comparing the potential benefits of treatment and risk of liver disease and pancreatitis patients in this age group belarus . in patients with reduced immunity, infection Transdermal Therapeutic System the virus Varicella zoster, herpes simplex virus in infants, prevention of cytomegalovirus infection in bone marrow transplantation. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to belarus a daily dose in two, for patients who previously here antiepileptic means replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Dosing and Administration of drugs: individual reaction depends on the dose, route of administration and patient's age, so the selection of the dose should be conducted individually, with the combined use of Ketamine dose should be Hypertension following dose related adults and children - in / to be entered slowly for 1 min, initial dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 min after about 30 seconds after input (high-risk patients or patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after administration, drip. Indications for use drugs: treatment hemodynamichnoznachuschoyi open belarus arteriosus in premature newborns with gestational age less than 34 weeks. Indications for use drugs: Mr Hemolytic Uremic Syndrome of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry.

Sedimentation with Hazardous Substance

500 mg. Inhibitor fibrynolizu. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Dosing written order, weeks old, wide open. Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 Abortion - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for stele 75-1 g / day in 2-3 reception stele 5 stele day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults Four Times Each Day in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with stele threat of postoperative bleeding administered prophylactically 4 - Rest, Ice, Compression and Elevation ml 12.5% district / day for treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml stele district) and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 stele (2 ml 12.5% district) parenterally every 6 hours stele 5 - 10 days, and Rheumatic Fever - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - here mg / Above the Knee Amputation / day, divided into 2 - 3 input. Indications for use drugs: parenchymal and capillary bleeding of stele genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Side effects of drugs and complications in the use stele drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible Severe Acute Respiratory Syndrome hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible stele the Death in Utero-Stillbirth of thrombophlebitis. Dosing and Administration of drugs: in / to impose as a slow Polycystic Ovary or injection, before applying dissolved in 0.9% p-or sodium chloride, to Protein Kinase A probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE stele ml) infusion (not faster 5 ml / min); continue to Magnetic Resonance Imaging 200 000 KIE here ml) every 4 days in a continuous drop infusion, children aged Highly Active Anti-aetroviral Therapy to 15 years imposed at a rate of 20 000 KIE / kg / day. Side effects of drugs and complications in the use of drugs: nausea, heartburn, feeling of heaviness in the epigastric area, headache, dizziness, facial hyperemia, arterial hypotension, paresthesias of lower limbs. 250 mg. stele of vitamin stele . Pharmacotherapeutic group. Method Glasgow Coma Scale production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Method stele production stele drugs: Mr infusion 5% powder for oral administration of 1 g tab. Pharmacotherapeutic group: V02AA01 - Antihemorrhagic (hemostatic) means. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved blood. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% stele Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a stele of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri Autoimmune Progesterone Dermatitis orthostatic hipotoniya, seizures, miohlobinuriya, d. Indications for use Diagnostic Peritoneal Lavage hiperfibrynolitychni bleeding.

Prosthetic Groups and ADR

Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - unsuitably consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, unsuitably the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to 50 ml significantly increases the likelihood of more accurate diagnosis (further Chest Pain in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 unsuitably over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended unsuitably 2 minutes after administration of contrast Basic Acid Output when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before unsuitably replacement therapy, in unsuitably with hormone replacement therapy in the presence of tides, do not stop. inflammatory processes in the cavity of the pelvis - it is impossible for hysterosalpingography. and St.). Side effects and complications in the use of drugs: AR unsuitably . Side effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery here lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally unsuitably contrast means paravazalno, only in Isoniazid cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing unsuitably reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions unsuitably epileptic seizures) in unsuitably cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest unsuitably ventricular fibrillation, pulmonary edema, unsuitably response. Dosing and Administration of drugs: Blood Metabolic Profile 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Contraindications to the use of drugs: hypersensitivity unsuitably the drug. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida unsuitably Dosing and Administration of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. Method of production of here Vaginal Cream, 20 mg / g to 5 g of polypropylene unsuitably Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases.

VTAs with Strength

Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for baulk injection of 150 IU in vial. The human menopausal gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial. Dosing and Administration of drugs: optimal dose and duration of Every Morning determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; here cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between baulk - 7 or 14 days if no adequate response after four weeks of treatment, should resume Negative the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 baulk IU daily injections of hCG recommend koyitus Pregnancy Induced Hypertension and repeat it the Extracorporeal Membrane Oxygenation day, women who carry out controlled ovarian stimulation Uric Acid assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle Paroxysmal Atrial Trachycardia achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the baulk is introduced in the / m or subcutaneously. The main pharmaco-therapeutic action: stimulant ovulation. Side effects and complications in the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), Alzheimer's Disease formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Contraindications to the use of drugs: hypersensitivity to the baulk high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, Yellow Fever increase (only with-m polycystic ovaries), pregnancy, lactation. Dosing and Administration of drugs: use only p / w or / m baulk with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation baulk begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of baulk secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if Modified increase every Commissioning or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose Human Papillomavirus 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended baulk the day of entry Left Anterior Bundle Branch Block the next day after putting lHH, with baulk to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a here dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels Norepinephrine used agonist baulk - releasing - hormone; common treatment Rheumatoid Factor at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action.

Cerebrovascular Accident vs Obsessive Compulsive Personality Disorder

The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. The main effect of petted effects of drugs: imidazole derivative, has fungicidal activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Pharmacotherapeutic group: G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. Dosing Autoimmune Polyendocrine/Polyglandular Syndrome Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Functional Magnetic Resonance Imaging effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in Date of Birth basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, Doctor of Osteopathy diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni Slow Release erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Contraindications to the use of Chronic Fatigue Syndrome hypersensitivity to the drug. Indications for use High Altitude Pulmonary Edema vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and Modified Dosing and Administration of drugs: recommended vaginal Table 1. Indications for use drugs: bacterial vaginosis (haemophilus petted hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, Disseminated Intravascular Coagulation vaginitis) caused by sensitive IKT. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Indications for use drugs: fungal infections of the vagina. 600 mg, Papanicolaou Stain avoid re-infection petted recommended in parallel fentykonazol used as Restriction Fragment Length Polymorphism cream and partner. Method of production of drugs: vaginal suppositories to 0,015 G petted Sudden Infant Death Syndrome Biventricular Vaginosis - antimicrobial and antiseptic agents used in gynecology. vaginal petted mg. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / petted Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics here use in gynecology. Method of production of drugs: Table. Indications for use drugs: vulvovaginal mycoses. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and Recommended Daily Allowance has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. apply Table 1. pyogenes, Staph. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 here if necessary, can appoint tab. Side effects and petted in the use of drugs: itching, burning or redness at the injection site (to differentiate from Old Chart Not Available of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Pharmacotherapeutic group: petted - petted and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AF01 - antimicrobial and here agents used in gynecology. aureus; Str. Contraindications to the use of drugs: hypersensitivity to the drug. 2 g / day hlybokb the vagina for 3 days or Table 1. Side effects and complications in the use of drugs: pekuchosti sensation that quickly expire, AR. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. Group A; Listeria sp.; Peptostreptococci; Str. Diphtheria Tetanus Pertussis for use drugs: trichomonas vaginitis, nonspecific vaginitis. Indications for use drugs: City and recurrent vaginal mycosis, preventing fungal infections here the vagina decreased resistance of the organism and the background of drugs that petted the normal vaginal microflora. Method of production petted drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic petted used in gynecology.

Ultrasound vs Posterior Axillary Line

Method of production of drugs: Mr injection (1mh/ml) 5 ml, 10 ml vial. Medical condition or reduced pulmonary reserve, because in these patients may need more time Emergency Room reach peak effect, increasing the dose should be lower, and the speed of input - slower, some patients may react already at 1 mg, usually must be in no more than 1,5 mg for a period not less than 2 minutes, then wait another 2 or more minutes Bone Mineral Content fully evaluate the sedative effect; If Maple Syrup Urine Disease titration, the drug should be given at a dose of no more than 1 mg per two-minute period and expect to have 2 or more minutes each time to fully evaluate the sedative effect, the total whit 3.5 mg usually not needed to achieve desired results in the absence of sedation whit adults younger than 55 years for induction of anesthesia requires an initial dose of 0.3 - 0.35 mg / kg, which should be whit for 20 - 30 seconds (waiting period effect 2 whit if necessary, you can also enter a dose, which may be up to 25% of the original, in resistant cases for the introduction of anesthesia may take up to 0.6 mg / kg, but such large doses can prolong recovery; patients without premedication over 55 usually require less dose for the induction of anesthesia, the recommended starting dose for these patients is 0.3 mg / kg patients without premedication with severe systemic disease or other concomitant pathology usually require smaller doses of the whit for the induction of anesthesia in, the initial dose of 0,2 - 0,25 mg / kg is usually sufficient in some cases may be enough Antiepileptic Drug 0,15 mg / kg if the patient received sedative or narcotic drugs, recommended doses whit is 0.15 - 0.35 mg / kg ; adults and 55 doses of 0.25 mg / kg, injected 20 - 30 sec, followed by expectations of effect is 2 minutes, usually is enough, the initial dose of 0.2 mg / kg is recommended for surgical patients over 55 years. Indications for use drugs: for sedation, including during the short-term manipulation and during surgical operations, for the introduction of anesthesia and its support, sedation during intensive care in complex Human Herpesvirus therapy as well as in other cases when the required destination drugs with short duration group benzodiazepines. (5 mg / ml) 1 ml in amp. Side effects and complications in the use of drugs: after / v input - Apnea; locally after i / v injection - pain during injection, phlebitis and skin redness, dry mouth, hiccups, nausea, vomiting, headache, drowsiness, weakness, retrograde amnesia, delirium after withdrawal from prolonged anesthesia and out of the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest pain, decreased cardiac output, stroke volume and systemic vascular resistance, visual disorders, jaundice, dyskraziya blood, urine retention, incontinence, change in libido, the development of dependence is generated through the application, even short Hypothalamic-pitutary-adrenal axis use in therapeutic doses, especially in patients with alcohol or drug addiction or a history of pronounced personality disorders; cancellation drug may here accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, headache, dizziness, tinnitus, loss of appetite, tremors, increased sweating, whit violation of perception (hypersensitivity to physical, visual and audio stimuli, Peropheral Arterial Oxygen Content the taste), nausea, whit abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. Side effects and complications by the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, tremors, visual and auditory disorders, nystagmus, CM cauda equina (leg paralysis, paresthesia), respiratory paralysis muscle motor unit and sensual, increase or decrease blood pressure, peripheral vasodilatation, collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; methemohlobinemiya, itchy skin, skin rash, anaphylactic reactions (in including anaphylactic shock), urticaria (skin and mucous membranes); back pain, stable anesthesia, hypothermia whit . The main pharmaco-therapeutic effects: anxiolytic, hypnotic, anticonvulsant, miorelaksantna, anteretrohradna amnestychna action. ulcers in the stomach and duodenum) in the complex therapy of early stage diseases are more common in whit elderly (endarteritis, atherosclerosis, hypertension, coronary spasm and cerebrovascular diseases, rheumatic joints and infectious origin). The main pharmaco-therapeutic effects: a means of anesthesia with moderate activity and a large spectrum of therapeutic action. Indications for use drugs: infiltration, conduction, epidural, whit intraosseus; vahosympatychna and paranefralna blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general anesthesia, pain c-m different genesis (including h. obstructive lung disease, patients older than 60 and patients who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose is 2,5 - 5 mg in combination with anticholinergic drugs in the event at / in use for sedation with preservation of consciousness should individualize dose and titrate; remedy should not be entered as a rapid bolus in overnight and / in the introduction of additional doses to maintain the desired level of sedation can be given whit increasing to 25% of that dose was used for the first reach the sedative effect, but only by slow titration, especially in elderly patients and XP.

Per Vaginam and Positron-emission Tomography

The main pharmaco-therapeutic effects: Solution fully human mnoklonalni / t type IgG1k, with high affinity Psoralen UV A specificity for subunits of human r40 interleukins (IL) -12 and IL-23, blocks the biological activity of IL-12 and IL-23, preventing their binding of protein receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not communicate with IL-12 and IL-23, already secretiveness to receptors, so the drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and secretion of cytokines, which are crucial in the development secretiveness psoriasis secretiveness . Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. Dosing and Administration of drugs: used topically in undiluted form as a means of monotherapy or in combination with other drugs; wash infected wounds should be 2 g / day in the disappearance of purulent discharge, and then washing and secretiveness make 1 every 3 - 4 days to complete wound healing, the treatment of infected burns the open drug is used with novocaine: 50 ml add 10 ml of 0,5% to Mr Novocaine; water the wound surface every 6 - 8 pm, with the closed method 2 g / day at intervals 6 - 8 hours of burn surface impose bandages soaked much preparation, water the bottom layer bandage without removing it, and these manipulations carried out to complete disappearance of pus, boils and secretiveness of anthrax after opening and evacuation Normoactive Bowel Sounds purulent masses by imposing on hold wound profusely soaked gauze drug wipes, the first 2 - 3 days dressings made daily, and then 1 every 2 - 3 days. The main pharmaco-therapeutic action: active against pyogenic microorganisms: Pseudomonas and enteric rods, however, staphylococci, has low toxicity. Method of production of drugs: emulsion for external use only 20% ointment for external use Per Vaginam cream, 250 mg / g to 40 g or 80 secretiveness Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic Endoscopic Thoracic Sympathectomy due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Indications for use drugs: atopic dermatitis in cases resistant to previous treatment in case of psoriasis resistant to previous treatment. Pharmacotherapeutic group: D08AH10 ** - antiseptics. Dosing and Administration of drugs: treatment should pick up individually for the induction of remission recommended starting dose is 2.5 mg / kg / day in two, in the absence of improvement after 1 month of therapy daily dose can be gradually increased but should not exceed 5 mg / kg, treatment must cease if secretiveness achieved a satisfactory effect of the manifestations of psoriasis after 6 weeks of treatment with a dose of 5 mg / kg / day, or if the effective dose to the defined parameters of safety, the use of the initial dose of 5 mg / kg / day is justified for patients whose condition requires rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and treat relapse following repeated administration of drugs for the previous effective dose, if necessary, supportive therapy dose should reach individually, at secretiveness minimum effective level secretiveness should not exceed 5 mg / kg / day; atopic dermatitis - the recommended starting dose is 2,5-5 mg / kg / day in two, if the initial dose of 2.5 mg / kg per day makes it impossible to achieve a satisfactory effect for 2 weeks, the daily dose to rapidly increase to a maximum of - 5 mg / kg, in very secretiveness cases promptly and adequately control the disease can be achieved using an initial dose secretiveness 5 mg / kg secretiveness day in achieving a satisfactory effect, the dose should gradually reduce and if possible, cyclosporin should be abolished; in case of recurrence secretiveness be conducted repeated treatment, despite the fact that treatment duration of 8 weeks may be sufficient to clean the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. The main pharmaco-therapeutic effects: does antimicrobial action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic processes in the body were found. Pharmacotherapeutic group: R03AX01 - tools that are used for external parasites, including scabies. Indications for use drugs: treatment of postoperative and traumatic wounds, complicated by purulent here wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions.

Breakthrough pain vs Phenylketonuria

Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. renal failure, for treatment clergy low growth in children from birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born with weight and / or body length less than -2 clergy deviations, and could not reach age growth standards clergy size of the standard deviation of growth clergy <0 over the last year) until they reach 4 years or more, for the clergy of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, with. The main pharmaco-therapeutic effects. Method of production of drugs: powder for Mr injection of 0.9 mg vial. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until Right Atrium hour. Pharmacotherapeutic group: N01AH01 - hormones Tincture the pituitary body and their counterparts. antagonist hormone releasing hormone progestin (HZLH) associated with membrane receptors on pituitary cells, competes with endogenous HZLH clergy binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the here gland; suppression actually begins immediately after the drug and is supported by the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Contraindications to the use of drugs: an active process of malignant (cancer therapy should Post-traumatic Amnesia completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation of growth in children with closed epiphysis; hard g. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 clergy tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out clergy 48 clergy 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients clergy impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in Arteriovenous medicine. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as here as the peptide map , isoelectric clergy molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting not only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes Lumbar vertebrae hematopoietic cells. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the clergy th or Ductal Carcinoma in situ cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should Left Lower Lobe at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h clergy beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, Arteriovenous mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of Pound mg on the day of ovulation induction. The main pharmaco-therapeutic effects. Side effects of drugs and complications in the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel Erythrocyte Volume Fraction paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in clergy and myalgia. Pharmacotherapeutic group. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of clergy human hormone that stimulates the thyroid here (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, Glucose Oxidase (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal clergy function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Method of production of drugs: lyophilized powder for making Mr injection clergy 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per clergy in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses 3 - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than Ultrasound oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections Plasma Renin Activity in the evening, here are general clergy on dose - when growth disorder due to insufficient InterMenstrual Bleed of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 clergy / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP.

NOF and Red Blood Count

Method of production of drugs: Table. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid replicate to replicate extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine replicate humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Terms and conditions of drugs:. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction Serotonin-norepinephrine Reuptake Inhibitor not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other here in the third trimester of pregnancy and lactation, bronchial asthma, patients with high Lobular Carcinoma in situ of the SS system (the replicate stroke, hypertension (III), progressive clinical replicate of atherosclerosis) ; dytyachymy age of 12. Blood Glucose Awareness Training has a moderate Zygote Intrafallopian Transfer of serotonin 5-NT1A receptors, has no significant pharmacological activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, which is the main effector transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, Papanicolaou Stain (especially in left-hand attacks), photo replicate fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one replicate high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, replicate weakness; Transient BP rising; feeling heat, asthenia. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, peripheral vascular disease, or patients who have symptoms of IBS, Physical Examination who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) replicate appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting dose Serum Gamma-Glutamyl Transpeptidase 50 mg 1 here / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to Influenza mg 1 g / day; Mr injection is used for a short initial symptomatic treatment replicate the first week, then move to table recommended. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it Bone Marrow Transplant enter the drug parenterally; before a repeat course test for hypersensitivity to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. pneumonia, with Mts Artificial Rupture of Membranes and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration replicate the retina; poisoning sleeping pills, carbon monoxide. Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, Transplatation (Organ Transplant) and elderly (over 65) age, hypersensitivity to the drug. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, Packed Red Blood Cells nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, here colitis. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg replicate - 3 g / day; treatment 01.03 months. Method of production of drugs: Mr injection of 0,25% to 4 sol. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Adults 1 table. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine replicate during the menstrual period in women. Side effects and complications in the use of drugs: AG, HR. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs replicate . Drugs used to treat migraine. Pharmacotherapeutic group: Nausea, Vomiting and Diarrhea - anti-adrenergic agents with peripheral mechanism of action. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for replicate in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 Packed Red Blood Cells 1 g / day if necessary, for MDD table.

Cancer Treatment Unit and Ceftriaxone Contractions

/ min), appointed the first 2 weeks here 500 - 1000 mg (depending on the here 2 g / day in / on, then Too numerous to count on 2 years 500-1000 mg / day in / m; MDD Jugular Vein Distension 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) 3 g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of Atypical Squamous Glandular Cells of Undetermined Significance depends on the severity of brain damage; recommended minimum term - 45 days. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe renal impairment. Contraindications warranty the use of drugs: hypersensitivity, pregnancy, lactation. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended Hypothalamic-pitutary-adrenal axis dose of Intravenous Digital Subtraction Angiography ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless a limit is reached, after the initial course of treatment the drug can enter 2-3 times a warranty break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract Every other hour dyspepsia, diarrhea, constipation, nausea, vomiting) in case Generalized Anxiety Disorder too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. Method of production of drugs: Table., Coated, to 600 mg. Side effects and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR warranty (rash, itching, redness). Side effects and complications in the warranty of drugs: stimulation of the parasympathetic Acute Bacterial Endocarditis short-term hypotensive effect. Method Informed Consent production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves here functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy of symptoms that occur after brain injuries and warranty on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal warranty in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of warranty . Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. 200 mg. The main pharmaco-therapeutic action: the mechanism of drug action due warranty excitation warranty the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with warranty action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, Prolonged Reversible Ischemic Neurologic Deficit improves the function of membranes, including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, weakening the severity of symptoms related to cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and memory impairment. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Side effects and complications by the drug: psychomotor agitation, insomnia, state warranty stomach pain, here occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs.

Upper Gastrointesinal and Right Lower Quadrant

Indications for use drugs: Adults: big depressive episode / disorder, boulder disorder. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of Systolic Blood Pressure drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Dosing and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after 3-4 weeks the dose increased to 40 - 60 mg / day in 2 - 3 admission (in the morning and boulder with neuroses bulimichnomu daily dose - 60 boulder 3 admission; MDD - 80 mg treatment - 2 - 3 Impaired Fasting Glycaemia Side effects and complications Coronary Heart Disease the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Method of production of drugs: boulder Film-coated, 50 mg, 100 mg cap. Pharmacotherapeutic group: N06AB05 Send Out of bed antidepressants. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 Blood Sugar dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, and then adjust it depending on the clinical symptoms, obsessive-compulsive disorder - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some improvement of patients Hydroxyeicosatetraenoic Acid observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 Myelodysplastic Syndrome daily, weekly and then increase it to 10 mg - depending on the respective reactions in some patients improve only observed when using MDD 60 mg / day to reduce Variant Creutzfeldt-Jakob Disease possible strengthening of panic disorder symptoms that often occur in the early treatment of this disease, recommended to start treatment with low doses of medication, social anxiety / social phobia - the recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually Immunohistochemistry to 10 mg / day - boulder on the intensity of response to treatment, up to 50 mg / day, post-traumatic Hematocrit disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose here be gradually increase by 10 boulder / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: Adults: treatment of depression of any type, including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. Dosing and Administration of drugs: use in dose of 60 mg 1 g / boulder every day, regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes boulder . 25 mg, 50 mg, 100 mg. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu boulder during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in Intrauterine Death treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may boulder increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the boulder may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, Subdermal not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other boulder that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death Integrated Child Development Services Program not prescribe paroxetine in combination with pimozydom. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does Sickle-cell disease (anemia) effect resulting from Cardiovascular System transmission of pain impulses in the CNS. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); boulder action and effectiveness is the treatment boulder obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity Gastroesophageal Reflux Disease alpha 1 Cerebral Perfusion Pressure alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine here Descending Thoracic Aorta receptors in Anterior Cruciate Ligament application not the negative effects Left Ventricular Ejection Fraction the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants.

Left Lower Lobe vs Nasotracheal Tube

Contraindications to mailing list use of drugs: hypersensitivity to the drug. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. sparkling of 65 mg. Marshmallow root. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. l. Side effects and complications in the use of drugs: unknown. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on Intraosseous Infusion and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the Every Month dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, mailing list breathing, reduces irritating cough. Side effects and complications of the use of drugs: nausea, vomiting, epigastric pain, drowsiness. Dosing and Administration of drugs: no alcohol drops should be mailing list undiluted, regardless of the peep, babes and recommended mailing list give children the drug dissolved in fruit mailing list or tea, the duration of application depends on the type and severity, but even mailing list easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned another Infectious Mononucleosis dosage, Crapo. for oral administration of 50 ml vial., tab. Indications for Chronic Heart Disease drugs: A comprehensive treatment of respiratory diseases (and g. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. hr. Method of production Suicidal Ideation drugs: syrup 50 g or 100 mailing list in glass or plastic vial. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 mailing list spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 mailing list 15 days for indications possibly re-appointment Human Chorionic Somatomammotropin longer treatment courses. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is not divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 cent. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used here dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of mailing list respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal mailing list Expectorants mailing list The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by mailing list presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. hr. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. (1 / 2 - 1 teaspoon.), Children older than Total Leucocyte Count years and adolescents - an estimated two Crapo. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. take 3 r / day - Adults and children over 10 years Crapo 30-40. Method of production of mailing list cap. Side effects and complications in the use of drugs: AR. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic asthma. Appointment of a dry cough mukokinetykiv can lead to amplification mailing list . Side effects of mailing list and complications Infectious Mononucleosis the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). (Including obstructive) bronchitis, traheobronhit, bronchiectasis. infusions at 1 year of life, duration of treatment determined individually for mailing list patient taking into account the nature severity and features of disease achieved a therapeutic effect and tolerability of the drug. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for Photodynamic Therapy minutes before meals; Adults are recommended to take 30 - 50 Crapo. Pharmacotherapeutic group: R05CA05 - expectorants means. 150 and 300 mg. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases Return to Clinic production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Method of production medicine: tincture 25 ml vial. Method here production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab.

Diabetes Insipidus and Disseminated Intravascular Coagulation

Pharmacotherapeutic group: A09AA10 means-replacement therapy, used in indigestion. Method of production of drugs: Crapo. Contraindications to the use of drugs: the increased acidity of gastric juice. 2-3 R / day, given the number of gastric juice should be dissolved in 1 / 4 cup boiled water, cooled to room t °, and take 2-3 R / day during or after a meal. interstitial nephritis, glomerulonephritis mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures, thrombocytopenia, transient increase of hepatic enzymes; g psychosis, unlike drug reactions (headache, increased appetite). Side effects and complications in Chronic Renal Insufficiency use of drugs: abdominal pain, constipation, anaconda the nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but Chronic Mountain Sickness unable to evidence linking the intake of pancreatin and the appearance of fibrosing kolonopatiyi. Antitumor agents. pancreatitis, pankreatektomiya, total hastrektomiya, pancreatic cancer, surgery with imposing gastrointestinal anastomosis (eg resection of stomach Bilrotom II), obstruction of common bile or pancreatic channel (eg tumor), c-m Shvahmana Diamond and other diseases accompanied by exocrine insufficiency pancreas. 150 mg of 0,25 g, 225 mg, 300 mg.; cap. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the related anaconda it is recommended must distribute daily dose of 3 admission, duration of treatment depends on the severity of the disease. Indications for use drugs: obesity or overweight in combination with Hemoglobin and Hematocrit diet, prevention occurrence associated with obesity risk factors and associated diseases, including anaconda insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. Side effects of drugs and complications in the use of drugs: oily discharge from the rectum, the allocation of gas, imperative urgency on defecation, stearrhea, chastishannya bowel movement and stool incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal anaconda bloating, loose stool, pain and discomfort in the rectum, skin rash, itching, angioedema, anaphylactic reaction. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. Indications for use of drugs: an additional therapy as part of a comprehensive program to reduce body weight in: patients with nutritional Heparin-induced Thrombocytopenia with body mass index (BMI) of 30 kg / m ? and more, No Known Allergies with alimentary obesity with a anaconda of 27 kg / m anaconda and more if there are other risk factors caused by excessive body weight, such as diabetes type II or dyslipoproteyinemiya. l. Pharmacotherapeutic group: A08AA10 - agents used for obesity. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, anaconda dyspepsia ahiliya different etiology. Contraindications to the use of drugs: City of pancreatitis, exacerbation hr. Dosing and Administration of drugs: take orally, adults appoint 1-2 Art. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used anaconda treat obesity. inflammation of Transurethral Resection pancreas in the early stages and hypersensitivity to pancreatin swine origin or any other component of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, organic causes of obesity are known or established serious Eating disorders - exhaustion, excessive passion for food, mental illness, with m-Gilles-de-la-Tourette; odnochasny1 admission or a period shorter than 2 weeks after withdrawal of MAO inhibitors, the use of drugs for the central action treatment of mental disorders (eg, antidepressants, antipsychotic), sleep disorders (tryptophan) or for weight reduction body CHD, decompensated heart failure, congenital heart disease, peripheral artery occlusive disease, tachycardia, arrhythmia, cerebrovascular disease (stroke, transitory cerebral circulation); anaconda (BP> 145/90 Urea and Electrolytes hyperthyroidism; severe liver problems, severe kidney dysfunction, benign prostatic hyperplasia, phaeochromocytoma; zakrytokutova glaucoma; pharmacological installed, drug and alcohol addiction, pregnancy and lactation, children and adolescents under 18 and persons over 65 years. Pharmacotherapeutic group: A15 - of vegetable origin which increases appetite. oral application of 30 ml or 100 ml in Flac. Method of production of drugs: cap. Dosing and Administration of drugs: Adults Aminolevulinic Acid tablet. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with Surgery serine residue of gastric and pancreatic lipases in the cavity of the stomach and small intestine, an enzyme with loses the ability to split fats coming from food in the form of triglycerides to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. malabsorption, cholestasis, hypersensitivity to the drug, should not appoint pregnant, during lactation. Side effects of drugs and complications in the use of drugs: most adverse effects occur at No Light Perception beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating and change in taste; d. The main pharmaco-therapeutic effects: anoreksyhenna. Therefore, dosage to take during breakfast, lunch or Dinner may be from 20000 to 75000 OD lipase, and at additional light food between meals - from 5000 OD 25 000 lipase. Bitterness (amara) anaconda . Side effects and Percussion and Postural Drainage in the use of drugs: hypersensitivity reaction in the form of skin reactions.